5 studies found for: Open Studies | "Hereditary Breast and Ovarian Cancer Syndrome"
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
|2||Not yet recruiting||
Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199
Efficacy of Lifestyle Intervention in BRCA1/2 Mutation Carriers
Cancer Genetics Hereditary Cancer Panel Testing
A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer
† Indicates status has not been verified in more than two years